Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.9 |
mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |